Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Ann Surg Oncol. 2018 Jul 5;25(10):3019–3029. doi: 10.1245/s10434-018-6587-2

Table 5.

Adjusted Hazard Ratios of ALND vs SLNB by Pathologic Response after Neoadjuvant Chemotherapy (N=2375)

Description ALND vs. SLNB HR (95% CI) Interaction P-Value
Pathologic Response 0.89
 No Complete Response 0.596 (0.435–0.816)
 Complete Response 0.621 (0.379–1.017)

These estimates are also adjusted for all covariates included in Table 4.